Congress is back this week with an agenda that appears light on health care so far as lobbyists, lawmakers and others continue to ponder how to navigate lobbying, legislating, and rulemaking in a world where the courts are no longer required -- yet still can -- defer to regulators’ interpretation of ambiguous statutory language in the wake of the Supreme Court’s ruling on Chevron . The House Energy & Commerce budget panel will grill the FTC chief at a hearing...